ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Long-term Pegylated Interferon Monotherapy Following 72 Weeks of Pegylated Interferon and Ribavirin in Hepatitis C Virus Genotype-1-infected Slow Responders
Internal Medicine
◽
10.2169/internalmedicine.54.2718
◽
2015
◽
Vol 54
(3)
◽
pp. 273-279
◽
Cited By ~ 2
Author(s):
Shinya Watanabe
◽
Yoshimasa Kobayashi
◽
Kazuhito Kawata
◽
Hidenao Noritake
◽
Takeshi Chida
◽
...
Keyword(s):
Hepatitis C Virus
◽
Hepatitis C
◽
Pegylated Interferon
◽
Genotype 1
◽
Virus Genotype
◽
Interferon Monotherapy
Download Full-text
Related Documents
Cited By
References
Projected long term impact of elbasvir/grazoprevir compared to sofosbuvir plus pegylated interferon/ribavirin in chronic hepatitis C virus genotype 1 and 4 patients in Italy: translation of the C-EDGE Head-2-Head study findings
Journal of Hepatology
◽
10.1016/s0168-8278(17)30914-5
◽
2017
◽
Vol 66
(1)
◽
pp. S298-S299
Author(s):
C. Nwankwo
◽
R. Batterson
◽
E. Todd
◽
Y. Jiang
◽
H.L. Platt
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C Virus
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Pegylated Interferon
◽
Genotype 1
◽
Virus Genotype
◽
Chronic Hepatitis C Virus
◽
Long Term Impact
Download Full-text
Faculty of 1000 evaluation for Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.
F1000 - Post-publication peer review of the biomedical literature
◽
10.3410/f.718020710.793480337
◽
2013
◽
Author(s):
Philip Rosenthal
Keyword(s):
Hepatitis C Virus
◽
Hepatitis C
◽
Pegylated Interferon
◽
Interferon Alfa
◽
Phase 2
◽
Genotype 1
◽
Virus Genotype
◽
Double Blind
◽
Phase 2 Trial
◽
Pegylated Interferon Alfa
Download Full-text
Faculty Opinions recommendation of Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718196356.793490906
◽
2014
◽
Author(s):
Arthur Kim
Keyword(s):
Hepatitis C Virus
◽
Hepatitis C
◽
Randomized Trial
◽
Low Dose
◽
Pegylated Interferon
◽
Genotype 1
◽
Virus Genotype
◽
Interferon Α2a
◽
Treatment Naïve
Download Full-text
Long‐term safety and efficacy results in hepatitis C virus genotype 1‒infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ‐I and TOPAZ‐II trials
Journal of Viral Hepatitis
◽
10.1111/jvh.13261
◽
2020
◽
Vol 27
(5)
◽
pp. 497-504
◽
Cited By ~ 1
Author(s):
Fred Poordad
◽
RuiSarmento E. Castro
◽
Armen Asatryan
◽
Humberto Aguilar
◽
Patrice Cacoub
◽
...
Keyword(s):
Hepatitis C Virus
◽
Hepatitis C
◽
Genotype 1
◽
Virus Genotype
◽
Safety And Efficacy
Download Full-text
SAT-255-Long-term safety and efficacy results in hepatitis C virus genotype 1-infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ-I and TOPAZ-II trials
Journal of Hepatology
◽
10.1016/s0618-8278(19)31488-4
◽
2019
◽
Vol 70
(1)
◽
pp. e745-e746
Author(s):
Fred Poordad
◽
Rui Sarmento E. Castro
◽
Armen Asatryan
◽
Humberto Aguilar
◽
Patrice Cacoub
◽
...
Keyword(s):
Hepatitis C Virus
◽
Hepatitis C
◽
Genotype 1
◽
Virus Genotype
◽
Safety And Efficacy
Download Full-text
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial
The Lancet Infectious Diseases
◽
10.1016/s1473-3099(13)70149-x
◽
2013
◽
Vol 13
(7)
◽
pp. 597-605
◽
Cited By ~ 147
Author(s):
Mark Sulkowski
◽
Stanislas Pol
◽
Josep Mallolas
◽
Hugo Fainboim
◽
Curtis Cooper
◽
...
Keyword(s):
Hepatitis C Virus
◽
Hepatitis C
◽
Pegylated Interferon
◽
Interferon Alfa
◽
Phase 2
◽
Genotype 1
◽
Virus Genotype
◽
Double Blind
◽
Phase 2 Trial
◽
Pegylated Interferon Alfa
Download Full-text
Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
DARU Journal of Pharmaceutical Sciences
◽
10.1186/s40199-017-0177-x
◽
2017
◽
Vol 25
(1)
◽
Cited By ~ 18
Author(s):
Fardin Dolatimehr
◽
Hamidreza Karimi-Sari
◽
Mohammad Saeid Rezaee-Zavareh
◽
Seyed Moayed Alavian
◽
Bita Behnava
◽
...
Keyword(s):
Systematic Review
◽
Hepatitis C Virus
◽
Hepatitis C
◽
Meta Analysis
◽
Pegylated Interferon
◽
Genotype 1
◽
Virus Genotype
Download Full-text
Clinical efficacy of combination therapy with ME3738 and pegylated interferon-alpha-2a in patients with hepatitis C virus genotype 1
Hepatology Research
◽
10.1111/hepr.12139
◽
2013
◽
Vol 44
(4)
◽
pp. 410-419
◽
Cited By ~ 3
Author(s):
Toshiji Saibara
◽
Nobuyuki Enomoto
◽
Shuichi Kaneko
◽
Kazuaki Chayama
◽
Michio Sata
◽
...
Keyword(s):
Hepatitis C Virus
◽
Hepatitis C
◽
Combination Therapy
◽
Interferon Alpha
◽
Clinical Efficacy
◽
Pegylated Interferon
◽
Genotype 1
◽
Virus Genotype
◽
Pegylated Interferon Alpha
Download Full-text
Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1
Journal of Gastroenterology
◽
10.1007/s00535-013-0824-z
◽
2013
◽
Vol 49
(4)
◽
pp. 737-747
◽
Cited By ~ 3
Author(s):
Tsugiko Oze
◽
Naoki Hiramatsu
◽
Takayuki Yakushijin
◽
Masanori Miyazaki
◽
Sadaharu Iio
◽
...
Keyword(s):
Hepatitis C Virus
◽
Hepatitis C
◽
Pegylated Interferon
◽
Genotype 1
◽
Virus Genotype
◽
Viral Kinetics
◽
Pegylated Interferon Plus Ribavirin
◽
Early Viral Kinetics
Download Full-text
Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1
Hepatitis Monthly
◽
10.5812/hepatmon.24955
◽
2015
◽
Vol 15
(1)
◽
Cited By ~ 5
Author(s):
Heidar Sharafi
◽
Seyed Moayed Alavian
◽
Maryam Keshvari
Keyword(s):
Hepatitis C Virus
◽
Hepatitis C
◽
Combination Therapy
◽
Interferon Alpha
◽
Pegylated Interferon
◽
Genotype 1
◽
Virus Genotype
◽
Pegylated Interferon Alpha
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close